의료 영상용 AI 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 모달리티별, 지역별 및 부문별 예측(2026-2033년)

AI In Medical Imaging Market Summary

The global AI in medical imaging market size was estimated at USD 1.8 billion in 2025 and is projected to reach USD 20.2 billion by 2033, growing at a CAGR of 35.11% from 2026 to 2033. Rising demand for early & accurate diagnosis, the increasing volume of imaging data, and technological advancements in artificial intelligence (AI) and machine learning (ML) are driving market growth.

In addition, the shortage of skilled radiologists, the growing adoption of telemedicine & remote diagnostics, and integration with PACS and cloud infrastructure further fuel market growth. The section below outlines the key factors driving the growth of AI in the medical imaging market, highlighting rising demand for AI-powered medical imaging solutions, rapid technological advancements in AI and medical imaging, advancements in AI-driven clinical decision support and imaging solutions,supportive government initiatives, and regulatory frameworks, and increasing government funding and strategic research collaboration.

Global AI In Medical Imaging Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global AI in medical imaging market report based on application, modality, technology, end-use, and region:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Deep Learning
• Natural Language Processing (NLP)
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Neurology
• Respiratory and Pulmonary
• Cardiology
• Breast Screening
• Orthopedics
• Others
• Modality Outlook (Revenue, USD Million, 2021 - 2033)
• CT Scan
• MRI
• X-rays
• Ultrasound
• Nuclear Imaging
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Technology Segment
  • 1.2.2. Application Segment
  • 1.2.3. Modality Segment
  • 1.2.4. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. AI in Medical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. AI in Medical Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
• 3.4. Case Study Insights

Chapter 4. AI in Medical Imaging Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global AI in Medical Imaging Market Technology Movement Analysis
• 4.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.4. Deep Learning
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Natural Language Processing (NLP)
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Medical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global AI in Medical Imaging Market Application Movement Analysis
• 5.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Neurology
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Respiratory and Pulmonary
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Breast Screening
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Orthopedics
  • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Medical Imaging Market: Modality Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global AI in Medical Imaging Market Modality Movement Analysis
• 6.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
• 6.4. CT Scan
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. MRI
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. X-rays
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Ultrasound
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Nuclear Imaging
  • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Medical Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global AI in Medical Imaging Market End Use Movement Analysis
• 7.3. Global AI in Medical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Medical Imaging Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.6. Norway
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. GE HealthCare
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Technology type benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Microsoft
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Technology type benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Digital Diagnostics Inc.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Technology type benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. TEMPUS
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Technology type benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Butterfly Network, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Technology type benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Advanced Micro Devices, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Technology type benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. HeartFlow, Inc.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Technology type benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Enlitic, Inc.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Technology type benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Canon Medical Systems USA, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Technology type benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Viz.ai, Inc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Technology type benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. EchoNous, Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Technology type benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. HeartVista Inc.
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Technology type benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Exo Imaging, Inc.
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Technology type benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Nano-X Imaging Ltd.
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Technology type benchmarking
    • 9.4.14.4. Strategic initiatives